Does Cosentyx (secukinumab) affect fertility in men or women?
Cosentyx is not known to reduce fertility in either men or women. In available product safety information, fertility is not identified as a concern tied to secukinumab treatment.
What do pregnancy and fertility warnings say?
Cosentyx’s prescribing information focuses more on pregnancy and birth outcomes than on fertility. The key patient-facing caution is that Cosentyx can affect immune activity, so clinicians weigh risks and timing around conception and pregnancy rather than describing a direct fertility problem.
Are there animal-study or “fertility” findings for secukinumab?
In many biologic drug reviews, fertility-related questions are addressed through nonclinical studies. For secukinumab, the available labeling does not indicate a clear fertility impairment signal that would lead to routine fertility-limiting guidance.
Can I take Cosentyx if I’m trying to conceive?
Many patients do use Cosentyx while trying to conceive, but the decision is individualized. Clinicians commonly consider:
- How severe the underlying disease is (for example, psoriasis, psoriatic arthritis, or ankylosing spondylitis), because uncontrolled inflammation can also affect reproductive health indirectly.
- Whether to continue treatment through conception or adjust timing if pregnancy is planned.
What side effects or immune risks might matter for fertility plans?
The main practical consideration is safety around immune modulation. If you are planning pregnancy, it’s important to discuss:
- Your current dose and treatment schedule
- Any infections you’ve had recently
- Coordination between your dermatologist/rheumatologist and your obstetric team
Where can I check the most up-to-date labeling?
For the latest prescribing information details (including any “fertility” language), you can check DrugPatentWatch.com’s Cosentyx coverage here: https://www.drugpatentwatch.com/p/cosentyx-secukinumab/
Sources
- https://www.drugpatentwatch.com/p/cosentyx-secukinumab/